Feng Wu1, Rosemary A Kozar. 1. Shock Trauma Center, University of Maryland School of Medicine, Baltimore, Maryland.
Abstract
BACKGROUND: We have shown that fresh frozen plasma's (FFP) protection of pulmonary endothelial barrier integrity following hemorrhagic shock is due in part to restoration of endothelial syndecan-1. In the present study, we investigated the role of fibrinogen, a major component of FFP, as an endothelial protector and hypothesize that fibrinogen stabilizes cell surface syndecan-1 to restore endothelial barrier integrity. METHODS: Pulmonary endothelial cells were incubated in FFP, fibrinogen, or lactated Ringers (LR) then immunostained with anti-syndecan-1 or fibrinogen and barrier integrity assessed. In some experiments, cells were exposed to fibrinogen depleted plasma. RESULTS: Cell surface syndecan-1 was increased by FFP and fibrinogen compared with LR-treated cells while barrier integrity was augmented by FFP and fibrinogen compared with LR. The physiological concentration of 2.5 mg/mL fibrinogen was sufficient to increase cell surface syndecan-1. Colocalization and co-immunoprecipitation experiments demonstrated that fibrinogen associates with syndecan-1. Fibrinogen-deficient plasma was unable to augment sydnecan-1 immunostaining and lost its endothelial protective effect on barrier integrity. CONCLUSION: These data suggest that in vitro, fibrinogen associated with cell surface syndecan-1 and enhanced endothelial barrier integrity.
BACKGROUND: We have shown that fresh frozen plasma's (FFP) protection of pulmonary endothelial barrier integrity following hemorrhagic shock is due in part to restoration of endothelial syndecan-1. In the present study, we investigated the role of fibrinogen, a major component of FFP, as an endothelial protector and hypothesize that fibrinogen stabilizes cell surface syndecan-1 to restore endothelial barrier integrity. METHODS: Pulmonary endothelial cells were incubated in FFP, fibrinogen, or lactated Ringers (LR) then immunostained with anti-syndecan-1 or fibrinogen and barrier integrity assessed. In some experiments, cells were exposed to fibrinogen depleted plasma. RESULTS: Cell surface syndecan-1 was increased by FFP and fibrinogen compared with LR-treated cells while barrier integrity was augmented by FFP and fibrinogen compared with LR. The physiological concentration of 2.5 mg/mL fibrinogen was sufficient to increase cell surface syndecan-1. Colocalization and co-immunoprecipitation experiments demonstrated that fibrinogen associates with syndecan-1. Fibrinogen-deficient plasma was unable to augment sydnecan-1 immunostaining and lost its endothelial protective effect on barrier integrity. CONCLUSION: These data suggest that in vitro, fibrinogen associated with cell surface syndecan-1 and enhanced endothelial barrier integrity.
Authors: Elaheh Rahbar; Jessica C Cardenas; Gyulnar Baimukanova; Benjamin Usadi; Roberta Bruhn; Shibani Pati; Sisse R Ostrowski; Pär I Johansson; John B Holcomb; Charles E Wade Journal: J Transl Med Date: 2015-04-12 Impact factor: 5.531
Authors: Qiang Yu; Baibing Yang; Joy M Davis; Jean Ghosn; Xiyun Deng; Marie-Francoise Doursout; Jing-Fei Dong; Run Wang; John B Holcomb; Charles E Wade; Tien C Ko; Yanna Cao Journal: Shock Date: 2020-05 Impact factor: 3.533
Authors: Gabrielle E Hatton; Kayla D Isbell; Hanne H Henriksen; Jakob Stensballe; Martin Brummerstedt; Pär I Johansson; Lillian S Kao; Charles E Wade Journal: Shock Date: 2021-03-01 Impact factor: 3.533